Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2026-06-12
• Last 15 days FTD volume: £0.07 M
• Last 3 months FTD volume: £18.77 M
• Last 12 months FTD volume: £34.03 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	£67.22 M	£0.15 B	🇺🇸 USA
Thermo Fisher Scientific TMO	£37.9 M	£92.26 M	🇺🇸 USA
General Electric GE	£24.24 M	£0.22 B	🇺🇸 USA
Bristol-Myers Squibb BMY	£5.87 M	£65.29 M	🇺🇸 USA
Sangamo Therapeutics SGMO	£1.32 M	£5.69 M	🇺🇸 USA
Novavax NVAX	£15.47 M	£57.27 M	🇺🇸 USA
Neurocrine Biosciences NBIX	£58.89 M	£68.05 M	🇺🇸 USA
Bio-Techne TECH	£89.98 M	£0.10 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£4.67 M	£14.82 M	🇺🇸 USA
Charles River Laboratories CRL	£6.44 M	£0.11 B	🇺🇸 USA